Global Artificial Blood Cells Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Artificial Blood Cells market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
LP Information, Inc. (LPI) ' newest research report, the “Artificial Blood Cells Industry Forecast” looks at past sales and reviews total world Artificial Blood Cells sales in 2024, providing a comprehensive analysis by region and market sector of projected Artificial Blood Cells sales for 2025 through 2031. With Artificial Blood Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Blood Cells industry.
This Insight Report provides a comprehensive analysis of the global Artificial Blood Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Blood Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Blood Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Blood Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Blood Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Blood Cells market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Artificial Blood Cells market?
What factors are driving Artificial Blood Cells market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Blood Cells market opportunities vary by end market size?
How does Artificial Blood Cells break out by Type, by Application?
The global Artificial Blood Cells market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
LP Information, Inc. (LPI) ' newest research report, the “Artificial Blood Cells Industry Forecast” looks at past sales and reviews total world Artificial Blood Cells sales in 2024, providing a comprehensive analysis by region and market sector of projected Artificial Blood Cells sales for 2025 through 2031. With Artificial Blood Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Blood Cells industry.
This Insight Report provides a comprehensive analysis of the global Artificial Blood Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Blood Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Blood Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Blood Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Blood Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Blood Cells market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Animal Hemoglobin
- Human Hemoglobin
- Stem Cell
- Others
- Cardiovascular Diseases
- Anemia
- Organ Transplant
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dextro-Sang Corporation
- BioPure Corporation
- Sangart
- Northfield Laboratories
- Baxter International
- Dentritech
- FluorO2 Therapeutics
- Nuvox Pharma
- Alpha Therapeutic Corporation
- HemoBioTech
What is the 10-year outlook for the global Artificial Blood Cells market?
What factors are driving Artificial Blood Cells market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Blood Cells market opportunities vary by end market size?
How does Artificial Blood Cells break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Blood Cells Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artificial Blood Cells by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artificial Blood Cells by Country/Region, 2020, 2024 & 2031
2.2 Artificial Blood Cells Segment by Type
2.2.1 Animal Hemoglobin
2.2.2 Human Hemoglobin
2.2.3 Stem Cell
2.2.4 Others
2.3 Artificial Blood Cells Sales by Type
2.3.1 Global Artificial Blood Cells Sales Market Share by Type (2020-2025)
2.3.2 Global Artificial Blood Cells Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artificial Blood Cells Sale Price by Type (2020-2025)
2.4 Artificial Blood Cells Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Anemia
2.4.3 Organ Transplant
2.4.4 Others
2.5 Artificial Blood Cells Sales by Application
2.5.1 Global Artificial Blood Cells Sale Market Share by Application (2020-2025)
2.5.2 Global Artificial Blood Cells Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artificial Blood Cells Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artificial Blood Cells Breakdown Data by Company
3.1.1 Global Artificial Blood Cells Annual Sales by Company (2020-2025)
3.1.2 Global Artificial Blood Cells Sales Market Share by Company (2020-2025)
3.2 Global Artificial Blood Cells Annual Revenue by Company (2020-2025)
3.2.1 Global Artificial Blood Cells Revenue by Company (2020-2025)
3.2.2 Global Artificial Blood Cells Revenue Market Share by Company (2020-2025)
3.3 Global Artificial Blood Cells Sale Price by Company
3.4 Key Manufacturers Artificial Blood Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Blood Cells Product Location Distribution
3.4.2 Players Artificial Blood Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTIFICIAL BLOOD CELLS BY GEOGRAPHIC REGION
4.1 World Historic Artificial Blood Cells Market Size by Geographic Region (2020-2025)
4.1.1 Global Artificial Blood Cells Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artificial Blood Cells Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artificial Blood Cells Market Size by Country/Region (2020-2025)
4.2.1 Global Artificial Blood Cells Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artificial Blood Cells Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artificial Blood Cells Sales Growth
4.4 APAC Artificial Blood Cells Sales Growth
4.5 Europe Artificial Blood Cells Sales Growth
4.6 Middle East & Africa Artificial Blood Cells Sales Growth
5 AMERICAS
5.1 Americas Artificial Blood Cells Sales by Country
5.1.1 Americas Artificial Blood Cells Sales by Country (2020-2025)
5.1.2 Americas Artificial Blood Cells Revenue by Country (2020-2025)
5.2 Americas Artificial Blood Cells Sales by Type (2020-2025)
5.3 Americas Artificial Blood Cells Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Blood Cells Sales by Region
6.1.1 APAC Artificial Blood Cells Sales by Region (2020-2025)
6.1.2 APAC Artificial Blood Cells Revenue by Region (2020-2025)
6.2 APAC Artificial Blood Cells Sales by Type (2020-2025)
6.3 APAC Artificial Blood Cells Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artificial Blood Cells by Country
7.1.1 Europe Artificial Blood Cells Sales by Country (2020-2025)
7.1.2 Europe Artificial Blood Cells Revenue by Country (2020-2025)
7.2 Europe Artificial Blood Cells Sales by Type (2020-2025)
7.3 Europe Artificial Blood Cells Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Blood Cells by Country
8.1.1 Middle East & Africa Artificial Blood Cells Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artificial Blood Cells Revenue by Country (2020-2025)
8.2 Middle East & Africa Artificial Blood Cells Sales by Type (2020-2025)
8.3 Middle East & Africa Artificial Blood Cells Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Blood Cells
10.3 Manufacturing Process Analysis of Artificial Blood Cells
10.4 Industry Chain Structure of Artificial Blood Cells
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Blood Cells Distributors
11.3 Artificial Blood Cells Customer
12 WORLD FORECAST REVIEW FOR ARTIFICIAL BLOOD CELLS BY GEOGRAPHIC REGION
12.1 Global Artificial Blood Cells Market Size Forecast by Region
12.1.1 Global Artificial Blood Cells Forecast by Region (2026-2031)
12.1.2 Global Artificial Blood Cells Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artificial Blood Cells Forecast by Type (2026-2031)
12.7 Global Artificial Blood Cells Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Dextro-Sang Corporation
13.1.1 Dextro-Sang Corporation Company Information
13.1.2 Dextro-Sang Corporation Artificial Blood Cells Product Portfolios and Specifications
13.1.3 Dextro-Sang Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Dextro-Sang Corporation Main Business Overview
13.1.5 Dextro-Sang Corporation Latest Developments
13.2 BioPure Corporation
13.2.1 BioPure Corporation Company Information
13.2.2 BioPure Corporation Artificial Blood Cells Product Portfolios and Specifications
13.2.3 BioPure Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BioPure Corporation Main Business Overview
13.2.5 BioPure Corporation Latest Developments
13.3 Sangart
13.3.1 Sangart Company Information
13.3.2 Sangart Artificial Blood Cells Product Portfolios and Specifications
13.3.3 Sangart Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sangart Main Business Overview
13.3.5 Sangart Latest Developments
13.4 Northfield Laboratories
13.4.1 Northfield Laboratories Company Information
13.4.2 Northfield Laboratories Artificial Blood Cells Product Portfolios and Specifications
13.4.3 Northfield Laboratories Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Northfield Laboratories Main Business Overview
13.4.5 Northfield Laboratories Latest Developments
13.5 Baxter International
13.5.1 Baxter International Company Information
13.5.2 Baxter International Artificial Blood Cells Product Portfolios and Specifications
13.5.3 Baxter International Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Baxter International Main Business Overview
13.5.5 Baxter International Latest Developments
13.6 Dentritech
13.6.1 Dentritech Company Information
13.6.2 Dentritech Artificial Blood Cells Product Portfolios and Specifications
13.6.3 Dentritech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dentritech Main Business Overview
13.6.5 Dentritech Latest Developments
13.7 FluorO2 Therapeutics
13.7.1 FluorO2 Therapeutics Company Information
13.7.2 FluorO2 Therapeutics Artificial Blood Cells Product Portfolios and Specifications
13.7.3 FluorO2 Therapeutics Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 FluorO2 Therapeutics Main Business Overview
13.7.5 FluorO2 Therapeutics Latest Developments
13.8 Nuvox Pharma
13.8.1 Nuvox Pharma Company Information
13.8.2 Nuvox Pharma Artificial Blood Cells Product Portfolios and Specifications
13.8.3 Nuvox Pharma Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nuvox Pharma Main Business Overview
13.8.5 Nuvox Pharma Latest Developments
13.9 Alpha Therapeutic Corporation
13.9.1 Alpha Therapeutic Corporation Company Information
13.9.2 Alpha Therapeutic Corporation Artificial Blood Cells Product Portfolios and Specifications
13.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Alpha Therapeutic Corporation Main Business Overview
13.9.5 Alpha Therapeutic Corporation Latest Developments
13.10 HemoBioTech
13.10.1 HemoBioTech Company Information
13.10.2 HemoBioTech Artificial Blood Cells Product Portfolios and Specifications
13.10.3 HemoBioTech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 HemoBioTech Main Business Overview
13.10.5 HemoBioTech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Blood Cells Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Artificial Blood Cells by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Artificial Blood Cells by Country/Region, 2020, 2024 & 2031
2.2 Artificial Blood Cells Segment by Type
2.2.1 Animal Hemoglobin
2.2.2 Human Hemoglobin
2.2.3 Stem Cell
2.2.4 Others
2.3 Artificial Blood Cells Sales by Type
2.3.1 Global Artificial Blood Cells Sales Market Share by Type (2020-2025)
2.3.2 Global Artificial Blood Cells Revenue and Market Share by Type (2020-2025)
2.3.3 Global Artificial Blood Cells Sale Price by Type (2020-2025)
2.4 Artificial Blood Cells Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Anemia
2.4.3 Organ Transplant
2.4.4 Others
2.5 Artificial Blood Cells Sales by Application
2.5.1 Global Artificial Blood Cells Sale Market Share by Application (2020-2025)
2.5.2 Global Artificial Blood Cells Revenue and Market Share by Application (2020-2025)
2.5.3 Global Artificial Blood Cells Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Artificial Blood Cells Breakdown Data by Company
3.1.1 Global Artificial Blood Cells Annual Sales by Company (2020-2025)
3.1.2 Global Artificial Blood Cells Sales Market Share by Company (2020-2025)
3.2 Global Artificial Blood Cells Annual Revenue by Company (2020-2025)
3.2.1 Global Artificial Blood Cells Revenue by Company (2020-2025)
3.2.2 Global Artificial Blood Cells Revenue Market Share by Company (2020-2025)
3.3 Global Artificial Blood Cells Sale Price by Company
3.4 Key Manufacturers Artificial Blood Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Blood Cells Product Location Distribution
3.4.2 Players Artificial Blood Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTIFICIAL BLOOD CELLS BY GEOGRAPHIC REGION
4.1 World Historic Artificial Blood Cells Market Size by Geographic Region (2020-2025)
4.1.1 Global Artificial Blood Cells Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Artificial Blood Cells Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Artificial Blood Cells Market Size by Country/Region (2020-2025)
4.2.1 Global Artificial Blood Cells Annual Sales by Country/Region (2020-2025)
4.2.2 Global Artificial Blood Cells Annual Revenue by Country/Region (2020-2025)
4.3 Americas Artificial Blood Cells Sales Growth
4.4 APAC Artificial Blood Cells Sales Growth
4.5 Europe Artificial Blood Cells Sales Growth
4.6 Middle East & Africa Artificial Blood Cells Sales Growth
5 AMERICAS
5.1 Americas Artificial Blood Cells Sales by Country
5.1.1 Americas Artificial Blood Cells Sales by Country (2020-2025)
5.1.2 Americas Artificial Blood Cells Revenue by Country (2020-2025)
5.2 Americas Artificial Blood Cells Sales by Type (2020-2025)
5.3 Americas Artificial Blood Cells Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Blood Cells Sales by Region
6.1.1 APAC Artificial Blood Cells Sales by Region (2020-2025)
6.1.2 APAC Artificial Blood Cells Revenue by Region (2020-2025)
6.2 APAC Artificial Blood Cells Sales by Type (2020-2025)
6.3 APAC Artificial Blood Cells Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artificial Blood Cells by Country
7.1.1 Europe Artificial Blood Cells Sales by Country (2020-2025)
7.1.2 Europe Artificial Blood Cells Revenue by Country (2020-2025)
7.2 Europe Artificial Blood Cells Sales by Type (2020-2025)
7.3 Europe Artificial Blood Cells Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Blood Cells by Country
8.1.1 Middle East & Africa Artificial Blood Cells Sales by Country (2020-2025)
8.1.2 Middle East & Africa Artificial Blood Cells Revenue by Country (2020-2025)
8.2 Middle East & Africa Artificial Blood Cells Sales by Type (2020-2025)
8.3 Middle East & Africa Artificial Blood Cells Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Blood Cells
10.3 Manufacturing Process Analysis of Artificial Blood Cells
10.4 Industry Chain Structure of Artificial Blood Cells
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Blood Cells Distributors
11.3 Artificial Blood Cells Customer
12 WORLD FORECAST REVIEW FOR ARTIFICIAL BLOOD CELLS BY GEOGRAPHIC REGION
12.1 Global Artificial Blood Cells Market Size Forecast by Region
12.1.1 Global Artificial Blood Cells Forecast by Region (2026-2031)
12.1.2 Global Artificial Blood Cells Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Artificial Blood Cells Forecast by Type (2026-2031)
12.7 Global Artificial Blood Cells Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Dextro-Sang Corporation
13.1.1 Dextro-Sang Corporation Company Information
13.1.2 Dextro-Sang Corporation Artificial Blood Cells Product Portfolios and Specifications
13.1.3 Dextro-Sang Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Dextro-Sang Corporation Main Business Overview
13.1.5 Dextro-Sang Corporation Latest Developments
13.2 BioPure Corporation
13.2.1 BioPure Corporation Company Information
13.2.2 BioPure Corporation Artificial Blood Cells Product Portfolios and Specifications
13.2.3 BioPure Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BioPure Corporation Main Business Overview
13.2.5 BioPure Corporation Latest Developments
13.3 Sangart
13.3.1 Sangart Company Information
13.3.2 Sangart Artificial Blood Cells Product Portfolios and Specifications
13.3.3 Sangart Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sangart Main Business Overview
13.3.5 Sangart Latest Developments
13.4 Northfield Laboratories
13.4.1 Northfield Laboratories Company Information
13.4.2 Northfield Laboratories Artificial Blood Cells Product Portfolios and Specifications
13.4.3 Northfield Laboratories Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Northfield Laboratories Main Business Overview
13.4.5 Northfield Laboratories Latest Developments
13.5 Baxter International
13.5.1 Baxter International Company Information
13.5.2 Baxter International Artificial Blood Cells Product Portfolios and Specifications
13.5.3 Baxter International Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Baxter International Main Business Overview
13.5.5 Baxter International Latest Developments
13.6 Dentritech
13.6.1 Dentritech Company Information
13.6.2 Dentritech Artificial Blood Cells Product Portfolios and Specifications
13.6.3 Dentritech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dentritech Main Business Overview
13.6.5 Dentritech Latest Developments
13.7 FluorO2 Therapeutics
13.7.1 FluorO2 Therapeutics Company Information
13.7.2 FluorO2 Therapeutics Artificial Blood Cells Product Portfolios and Specifications
13.7.3 FluorO2 Therapeutics Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 FluorO2 Therapeutics Main Business Overview
13.7.5 FluorO2 Therapeutics Latest Developments
13.8 Nuvox Pharma
13.8.1 Nuvox Pharma Company Information
13.8.2 Nuvox Pharma Artificial Blood Cells Product Portfolios and Specifications
13.8.3 Nuvox Pharma Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nuvox Pharma Main Business Overview
13.8.5 Nuvox Pharma Latest Developments
13.9 Alpha Therapeutic Corporation
13.9.1 Alpha Therapeutic Corporation Company Information
13.9.2 Alpha Therapeutic Corporation Artificial Blood Cells Product Portfolios and Specifications
13.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Alpha Therapeutic Corporation Main Business Overview
13.9.5 Alpha Therapeutic Corporation Latest Developments
13.10 HemoBioTech
13.10.1 HemoBioTech Company Information
13.10.2 HemoBioTech Artificial Blood Cells Product Portfolios and Specifications
13.10.3 HemoBioTech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 HemoBioTech Main Business Overview
13.10.5 HemoBioTech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Blood Cells Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artificial Blood Cells Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Animal Hemoglobin
Table 4. Major Players of Human Hemoglobin
Table 5. Major Players of Stem Cell
Table 6. Major Players of Others
Table 7. Global Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 8. Global Artificial Blood Cells Sales Market Share by Type (2020-2025)
Table 9. Global Artificial Blood Cells Revenue by Type (2020-2025) & ($ million)
Table 10. Global Artificial Blood Cells Revenue Market Share by Type (2020-2025)
Table 11. Global Artificial Blood Cells Sale Price by Type (2020-2025) & (US$/Unit)
Table 12. Global Artificial Blood Cells Sale by Application (2020-2025) & (K Units)
Table 13. Global Artificial Blood Cells Sale Market Share by Application (2020-2025)
Table 14. Global Artificial Blood Cells Revenue by Application (2020-2025) & ($ million)
Table 15. Global Artificial Blood Cells Revenue Market Share by Application (2020-2025)
Table 16. Global Artificial Blood Cells Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Artificial Blood Cells Sales by Company (2020-2025) & (K Units)
Table 18. Global Artificial Blood Cells Sales Market Share by Company (2020-2025)
Table 19. Global Artificial Blood Cells Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Artificial Blood Cells Revenue Market Share by Company (2020-2025)
Table 21. Global Artificial Blood Cells Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Artificial Blood Cells Producing Area Distribution and Sales Area
Table 23. Players Artificial Blood Cells Products Offered
Table 24. Artificial Blood Cells Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Artificial Blood Cells Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Artificial Blood Cells Sales Market Share Geographic Region (2020-2025)
Table 29. Global Artificial Blood Cells Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Artificial Blood Cells Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Artificial Blood Cells Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Artificial Blood Cells Sales Market Share by Country/Region (2020-2025)
Table 33. Global Artificial Blood Cells Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Artificial Blood Cells Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
Table 36. Americas Artificial Blood Cells Sales Market Share by Country (2020-2025)
Table 37. Americas Artificial Blood Cells Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 39. Americas Artificial Blood Cells Sales by Application (2020-2025) & (K Units)
Table 40. APAC Artificial Blood Cells Sales by Region (2020-2025) & (K Units)
Table 41. APAC Artificial Blood Cells Sales Market Share by Region (2020-2025)
Table 42. APAC Artificial Blood Cells Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 44. APAC Artificial Blood Cells Sales by Application (2020-2025) & (K Units)
Table 45. Europe Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
Table 46. Europe Artificial Blood Cells Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 48. Europe Artificial Blood Cells Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Artificial Blood Cells Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Artificial Blood Cells Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Artificial Blood Cells
Table 54. Key Market Challenges & Risks of Artificial Blood Cells
Table 55. Key Industry Trends of Artificial Blood Cells
Table 56. Artificial Blood Cells Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Artificial Blood Cells Distributors List
Table 59. Artificial Blood Cells Customer List
Table 60. Global Artificial Blood Cells Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Artificial Blood Cells Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Artificial Blood Cells Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Artificial Blood Cells Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Artificial Blood Cells Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Artificial Blood Cells Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Artificial Blood Cells Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Artificial Blood Cells Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Artificial Blood Cells Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Artificial Blood Cells Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Artificial Blood Cells Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Artificial Blood Cells Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Artificial Blood Cells Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Artificial Blood Cells Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Dextro-Sang Corporation Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 75. Dextro-Sang Corporation Artificial Blood Cells Product Portfolios and Specifications
Table 76. Dextro-Sang Corporation Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. Dextro-Sang Corporation Main Business
Table 78. Dextro-Sang Corporation Latest Developments
Table 79. BioPure Corporation Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 80. BioPure Corporation Artificial Blood Cells Product Portfolios and Specifications
Table 81. BioPure Corporation Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. BioPure Corporation Main Business
Table 83. BioPure Corporation Latest Developments
Table 84. Sangart Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 85. Sangart Artificial Blood Cells Product Portfolios and Specifications
Table 86. Sangart Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Sangart Main Business
Table 88. Sangart Latest Developments
Table 89. Northfield Laboratories Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 90. Northfield Laboratories Artificial Blood Cells Product Portfolios and Specifications
Table 91. Northfield Laboratories Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Northfield Laboratories Main Business
Table 93. Northfield Laboratories Latest Developments
Table 94. Baxter International Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 95. Baxter International Artificial Blood Cells Product Portfolios and Specifications
Table 96. Baxter International Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Baxter International Main Business
Table 98. Baxter International Latest Developments
Table 99. Dentritech Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 100. Dentritech Artificial Blood Cells Product Portfolios and Specifications
Table 101. Dentritech Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Dentritech Main Business
Table 103. Dentritech Latest Developments
Table 104. FluorO2 Therapeutics Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 105. FluorO2 Therapeutics Artificial Blood Cells Product Portfolios and Specifications
Table 106. FluorO2 Therapeutics Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. FluorO2 Therapeutics Main Business
Table 108. FluorO2 Therapeutics Latest Developments
Table 109. Nuvox Pharma Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 110. Nuvox Pharma Artificial Blood Cells Product Portfolios and Specifications
Table 111. Nuvox Pharma Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Nuvox Pharma Main Business
Table 113. Nuvox Pharma Latest Developments
Table 114. Alpha Therapeutic Corporation Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 115. Alpha Therapeutic Corporation Artificial Blood Cells Product Portfolios and Specifications
Table 116. Alpha Therapeutic Corporation Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. Alpha Therapeutic Corporation Main Business
Table 118. Alpha Therapeutic Corporation Latest Developments
Table 119. HemoBioTech Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 120. HemoBioTech Artificial Blood Cells Product Portfolios and Specifications
Table 121. HemoBioTech Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. HemoBioTech Main Business
Table 123. HemoBioTech Latest Developments
Table 1. Artificial Blood Cells Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Artificial Blood Cells Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Animal Hemoglobin
Table 4. Major Players of Human Hemoglobin
Table 5. Major Players of Stem Cell
Table 6. Major Players of Others
Table 7. Global Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 8. Global Artificial Blood Cells Sales Market Share by Type (2020-2025)
Table 9. Global Artificial Blood Cells Revenue by Type (2020-2025) & ($ million)
Table 10. Global Artificial Blood Cells Revenue Market Share by Type (2020-2025)
Table 11. Global Artificial Blood Cells Sale Price by Type (2020-2025) & (US$/Unit)
Table 12. Global Artificial Blood Cells Sale by Application (2020-2025) & (K Units)
Table 13. Global Artificial Blood Cells Sale Market Share by Application (2020-2025)
Table 14. Global Artificial Blood Cells Revenue by Application (2020-2025) & ($ million)
Table 15. Global Artificial Blood Cells Revenue Market Share by Application (2020-2025)
Table 16. Global Artificial Blood Cells Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Artificial Blood Cells Sales by Company (2020-2025) & (K Units)
Table 18. Global Artificial Blood Cells Sales Market Share by Company (2020-2025)
Table 19. Global Artificial Blood Cells Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Artificial Blood Cells Revenue Market Share by Company (2020-2025)
Table 21. Global Artificial Blood Cells Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Artificial Blood Cells Producing Area Distribution and Sales Area
Table 23. Players Artificial Blood Cells Products Offered
Table 24. Artificial Blood Cells Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Artificial Blood Cells Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Artificial Blood Cells Sales Market Share Geographic Region (2020-2025)
Table 29. Global Artificial Blood Cells Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Artificial Blood Cells Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Artificial Blood Cells Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Artificial Blood Cells Sales Market Share by Country/Region (2020-2025)
Table 33. Global Artificial Blood Cells Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Artificial Blood Cells Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
Table 36. Americas Artificial Blood Cells Sales Market Share by Country (2020-2025)
Table 37. Americas Artificial Blood Cells Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 39. Americas Artificial Blood Cells Sales by Application (2020-2025) & (K Units)
Table 40. APAC Artificial Blood Cells Sales by Region (2020-2025) & (K Units)
Table 41. APAC Artificial Blood Cells Sales Market Share by Region (2020-2025)
Table 42. APAC Artificial Blood Cells Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 44. APAC Artificial Blood Cells Sales by Application (2020-2025) & (K Units)
Table 45. Europe Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
Table 46. Europe Artificial Blood Cells Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 48. Europe Artificial Blood Cells Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Artificial Blood Cells Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Artificial Blood Cells Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Artificial Blood Cells Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Artificial Blood Cells Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Artificial Blood Cells
Table 54. Key Market Challenges & Risks of Artificial Blood Cells
Table 55. Key Industry Trends of Artificial Blood Cells
Table 56. Artificial Blood Cells Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Artificial Blood Cells Distributors List
Table 59. Artificial Blood Cells Customer List
Table 60. Global Artificial Blood Cells Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Artificial Blood Cells Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Artificial Blood Cells Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Artificial Blood Cells Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Artificial Blood Cells Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Artificial Blood Cells Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Artificial Blood Cells Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Artificial Blood Cells Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Artificial Blood Cells Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Artificial Blood Cells Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Artificial Blood Cells Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Artificial Blood Cells Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Artificial Blood Cells Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Artificial Blood Cells Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Dextro-Sang Corporation Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 75. Dextro-Sang Corporation Artificial Blood Cells Product Portfolios and Specifications
Table 76. Dextro-Sang Corporation Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. Dextro-Sang Corporation Main Business
Table 78. Dextro-Sang Corporation Latest Developments
Table 79. BioPure Corporation Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 80. BioPure Corporation Artificial Blood Cells Product Portfolios and Specifications
Table 81. BioPure Corporation Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. BioPure Corporation Main Business
Table 83. BioPure Corporation Latest Developments
Table 84. Sangart Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 85. Sangart Artificial Blood Cells Product Portfolios and Specifications
Table 86. Sangart Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Sangart Main Business
Table 88. Sangart Latest Developments
Table 89. Northfield Laboratories Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 90. Northfield Laboratories Artificial Blood Cells Product Portfolios and Specifications
Table 91. Northfield Laboratories Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Northfield Laboratories Main Business
Table 93. Northfield Laboratories Latest Developments
Table 94. Baxter International Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 95. Baxter International Artificial Blood Cells Product Portfolios and Specifications
Table 96. Baxter International Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Baxter International Main Business
Table 98. Baxter International Latest Developments
Table 99. Dentritech Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 100. Dentritech Artificial Blood Cells Product Portfolios and Specifications
Table 101. Dentritech Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Dentritech Main Business
Table 103. Dentritech Latest Developments
Table 104. FluorO2 Therapeutics Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 105. FluorO2 Therapeutics Artificial Blood Cells Product Portfolios and Specifications
Table 106. FluorO2 Therapeutics Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. FluorO2 Therapeutics Main Business
Table 108. FluorO2 Therapeutics Latest Developments
Table 109. Nuvox Pharma Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 110. Nuvox Pharma Artificial Blood Cells Product Portfolios and Specifications
Table 111. Nuvox Pharma Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Nuvox Pharma Main Business
Table 113. Nuvox Pharma Latest Developments
Table 114. Alpha Therapeutic Corporation Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 115. Alpha Therapeutic Corporation Artificial Blood Cells Product Portfolios and Specifications
Table 116. Alpha Therapeutic Corporation Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. Alpha Therapeutic Corporation Main Business
Table 118. Alpha Therapeutic Corporation Latest Developments
Table 119. HemoBioTech Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 120. HemoBioTech Artificial Blood Cells Product Portfolios and Specifications
Table 121. HemoBioTech Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. HemoBioTech Main Business
Table 123. HemoBioTech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Artificial Blood Cells
Figure 2. Artificial Blood Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Blood Cells Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Artificial Blood Cells Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artificial Blood Cells Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artificial Blood Cells Sales Market Share by Country/Region (2024)
Figure 10. Artificial Blood Cells Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Animal Hemoglobin
Figure 12. Product Picture of Human Hemoglobin
Figure 13. Product Picture of Stem Cell
Figure 14. Product Picture of Others
Figure 15. Global Artificial Blood Cells Sales Market Share by Type in 2025
Figure 16. Global Artificial Blood Cells Revenue Market Share by Type (2020-2025)
Figure 17. Artificial Blood Cells Consumed in Cardiovascular Diseases
Figure 18. Global Artificial Blood Cells Market: Cardiovascular Diseases (2020-2025) & (K Units)
Figure 19. Artificial Blood Cells Consumed in Anemia
Figure 20. Global Artificial Blood Cells Market: Anemia (2020-2025) & (K Units)
Figure 21. Artificial Blood Cells Consumed in Organ Transplant
Figure 22. Global Artificial Blood Cells Market: Organ Transplant (2020-2025) & (K Units)
Figure 23. Artificial Blood Cells Consumed in Others
Figure 24. Global Artificial Blood Cells Market: Others (2020-2025) & (K Units)
Figure 25. Global Artificial Blood Cells Sale Market Share by Application (2024)
Figure 26. Global Artificial Blood Cells Revenue Market Share by Application in 2025
Figure 27. Artificial Blood Cells Sales by Company in 2025 (K Units)
Figure 28. Global Artificial Blood Cells Sales Market Share by Company in 2025
Figure 29. Artificial Blood Cells Revenue by Company in 2025 ($ millions)
Figure 30. Global Artificial Blood Cells Revenue Market Share by Company in 2025
Figure 31. Global Artificial Blood Cells Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Artificial Blood Cells Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Artificial Blood Cells Sales 2020-2025 (K Units)
Figure 34. Americas Artificial Blood Cells Revenue 2020-2025 ($ millions)
Figure 35. APAC Artificial Blood Cells Sales 2020-2025 (K Units)
Figure 36. APAC Artificial Blood Cells Revenue 2020-2025 ($ millions)
Figure 37. Europe Artificial Blood Cells Sales 2020-2025 (K Units)
Figure 38. Europe Artificial Blood Cells Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Artificial Blood Cells Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Artificial Blood Cells Revenue 2020-2025 ($ millions)
Figure 41. Americas Artificial Blood Cells Sales Market Share by Country in 2025
Figure 42. Americas Artificial Blood Cells Revenue Market Share by Country (2020-2025)
Figure 43. Americas Artificial Blood Cells Sales Market Share by Type (2020-2025)
Figure 44. Americas Artificial Blood Cells Sales Market Share by Application (2020-2025)
Figure 45. United States Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Artificial Blood Cells Sales Market Share by Region in 2025
Figure 50. APAC Artificial Blood Cells Revenue Market Share by Region (2020-2025)
Figure 51. APAC Artificial Blood Cells Sales Market Share by Type (2020-2025)
Figure 52. APAC Artificial Blood Cells Sales Market Share by Application (2020-2025)
Figure 53. China Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 57. India Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Artificial Blood Cells Sales Market Share by Country in 2025
Figure 61. Europe Artificial Blood Cells Revenue Market Share by Country (2020-2025)
Figure 62. Europe Artificial Blood Cells Sales Market Share by Type (2020-2025)
Figure 63. Europe Artificial Blood Cells Sales Market Share by Application (2020-2025)
Figure 64. Germany Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 65. France Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Artificial Blood Cells Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Artificial Blood Cells Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Artificial Blood Cells Sales Market Share by Application (2020-2025)
Figure 72. Egypt Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Artificial Blood Cells in 2025
Figure 78. Manufacturing Process Analysis of Artificial Blood Cells
Figure 79. Industry Chain Structure of Artificial Blood Cells
Figure 80. Channels of Distribution
Figure 81. Global Artificial Blood Cells Sales Market Forecast by Region (2026-2031)
Figure 82. Global Artificial Blood Cells Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Artificial Blood Cells Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Artificial Blood Cells Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Artificial Blood Cells Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Artificial Blood Cells Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Artificial Blood Cells
Figure 2. Artificial Blood Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Blood Cells Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Artificial Blood Cells Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Artificial Blood Cells Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Artificial Blood Cells Sales Market Share by Country/Region (2024)
Figure 10. Artificial Blood Cells Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Animal Hemoglobin
Figure 12. Product Picture of Human Hemoglobin
Figure 13. Product Picture of Stem Cell
Figure 14. Product Picture of Others
Figure 15. Global Artificial Blood Cells Sales Market Share by Type in 2025
Figure 16. Global Artificial Blood Cells Revenue Market Share by Type (2020-2025)
Figure 17. Artificial Blood Cells Consumed in Cardiovascular Diseases
Figure 18. Global Artificial Blood Cells Market: Cardiovascular Diseases (2020-2025) & (K Units)
Figure 19. Artificial Blood Cells Consumed in Anemia
Figure 20. Global Artificial Blood Cells Market: Anemia (2020-2025) & (K Units)
Figure 21. Artificial Blood Cells Consumed in Organ Transplant
Figure 22. Global Artificial Blood Cells Market: Organ Transplant (2020-2025) & (K Units)
Figure 23. Artificial Blood Cells Consumed in Others
Figure 24. Global Artificial Blood Cells Market: Others (2020-2025) & (K Units)
Figure 25. Global Artificial Blood Cells Sale Market Share by Application (2024)
Figure 26. Global Artificial Blood Cells Revenue Market Share by Application in 2025
Figure 27. Artificial Blood Cells Sales by Company in 2025 (K Units)
Figure 28. Global Artificial Blood Cells Sales Market Share by Company in 2025
Figure 29. Artificial Blood Cells Revenue by Company in 2025 ($ millions)
Figure 30. Global Artificial Blood Cells Revenue Market Share by Company in 2025
Figure 31. Global Artificial Blood Cells Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Artificial Blood Cells Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Artificial Blood Cells Sales 2020-2025 (K Units)
Figure 34. Americas Artificial Blood Cells Revenue 2020-2025 ($ millions)
Figure 35. APAC Artificial Blood Cells Sales 2020-2025 (K Units)
Figure 36. APAC Artificial Blood Cells Revenue 2020-2025 ($ millions)
Figure 37. Europe Artificial Blood Cells Sales 2020-2025 (K Units)
Figure 38. Europe Artificial Blood Cells Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Artificial Blood Cells Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Artificial Blood Cells Revenue 2020-2025 ($ millions)
Figure 41. Americas Artificial Blood Cells Sales Market Share by Country in 2025
Figure 42. Americas Artificial Blood Cells Revenue Market Share by Country (2020-2025)
Figure 43. Americas Artificial Blood Cells Sales Market Share by Type (2020-2025)
Figure 44. Americas Artificial Blood Cells Sales Market Share by Application (2020-2025)
Figure 45. United States Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Artificial Blood Cells Sales Market Share by Region in 2025
Figure 50. APAC Artificial Blood Cells Revenue Market Share by Region (2020-2025)
Figure 51. APAC Artificial Blood Cells Sales Market Share by Type (2020-2025)
Figure 52. APAC Artificial Blood Cells Sales Market Share by Application (2020-2025)
Figure 53. China Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 57. India Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Artificial Blood Cells Sales Market Share by Country in 2025
Figure 61. Europe Artificial Blood Cells Revenue Market Share by Country (2020-2025)
Figure 62. Europe Artificial Blood Cells Sales Market Share by Type (2020-2025)
Figure 63. Europe Artificial Blood Cells Sales Market Share by Application (2020-2025)
Figure 64. Germany Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 65. France Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Artificial Blood Cells Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Artificial Blood Cells Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Artificial Blood Cells Sales Market Share by Application (2020-2025)
Figure 72. Egypt Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Artificial Blood Cells Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Artificial Blood Cells in 2025
Figure 78. Manufacturing Process Analysis of Artificial Blood Cells
Figure 79. Industry Chain Structure of Artificial Blood Cells
Figure 80. Channels of Distribution
Figure 81. Global Artificial Blood Cells Sales Market Forecast by Region (2026-2031)
Figure 82. Global Artificial Blood Cells Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Artificial Blood Cells Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Artificial Blood Cells Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Artificial Blood Cells Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Artificial Blood Cells Revenue Market Share Forecast by Application (2026-2031)
